Bureau Veritas SA
PAR:BVI
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
21.44
30.64
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bureau Veritas SA
Capital Expenditures
Bureau Veritas SA
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Bureau Veritas SA
PAR:BVI
|
Capital Expenditures
-€139.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
0%
|
||
Teleperformance SE
PAR:TEP
|
Capital Expenditures
-€209m
|
CAGR 3-Years
4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
||
GECI International SA
PAR:ALGEC
|
Capital Expenditures
-€239k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
||
Alan Allman Associates SA
PAR:AAA
|
Capital Expenditures
-€4.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Assystem SA
PAR:ASY
|
Capital Expenditures
-€3.9m
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
9%
|
||
Neolife SA
PAR:ALNLF
|
Capital Expenditures
-€285.2k
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Bureau Veritas SA
Glance View
Bureau Veritas SA, founded in 1828, has evolved into a global leader in testing, inspection, and certification services. With its headquarters in Neuilly-sur-Seine, France, the company has built a remarkable reputation for ensuring that products, infrastructure, and systems meet stringent quality and safety standards. Operating in a diverse range of sectors, including construction, manufacturing, oil & gas, and automotive, Bureau Veritas helps businesses navigate the complexities of compliance and risk management, making it an essential partner in the global supply chain. Its commitment to sustainability and innovation is reflected in its continuous investment in technology and digital solutions, which enhance efficiency and adapt to the dynamic needs of clients worldwide. For investors, Bureau Veritas represents a compelling opportunity in the ever-growing markets of environmental, social, and governance (ESG) compliance—an area becoming increasingly paramount for corporations worldwide. The company’s robust financial performance, evidenced by steady revenue growth and a strong balance sheet, positions it well for future expansion. With a strong international presence in over 140 countries and a diverse portfolio, Bureau Veritas not only mitigates risks associated with economic fluctuations but also capitalizes on emerging trends in sustainability and regulatory requirements. As companies seek to enhance trust and transparency in their operations, Bureau Veritas stands out as a reliable partner poised for enduring success, making it a noteworthy consideration for any discerning investor.
See Also
What is Bureau Veritas SA's Capital Expenditures?
Capital Expenditures
-139.4m
EUR
Based on the financial report for Jun 30, 2024, Bureau Veritas SA's Capital Expenditures amounts to -139.4m EUR.
What is Bureau Veritas SA's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
0%
Over the last year, the Capital Expenditures growth was 11%. The average annual Capital Expenditures growth rates for Bureau Veritas SA have been -8% over the past three years , -2% over the past five years .